Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

856 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Ezetimibe Lipid-Lowering Trial on Prevention of Atherosclerotic Cardiovascular Disease in 75 or Older (EWTOPIA 75): A Randomized, Controlled Trial.
Ouchi Y, Sasaki J, Arai H, Yokote K, Harada K, Katayama Y, Urabe T, Uchida Y, Hayashi M, Yokota N, Nishida H, Otonari T, Arai T, Sakuma I, Sakabe K, Yamamoto M, Kobayashi T, Oikawa S, Yamashita S, Rakugi H, Imai T, Tanaka S, Ohashi Y, Kuwabara M, Ito H. Ouchi Y, et al. Among authors: oikawa s. Circulation. 2019 Sep 17;140(12):992-1003. doi: 10.1161/CIRCULATIONAHA.118.039415. Epub 2019 Aug 22. Circulation. 2019. PMID: 31434507 Clinical Trial.
Effectiveness and Safety of Lipid-Lowering Drug Treatments in Japanese Patients with Familial Hypercholesterolemia: Familial Hypercholesterolemia Expert Forum (FAME) Study.
Yamashita S, Masuda D, Harada-Shiba M, Arai H, Bujo H, Ishibashi S, Daida H, Koga N, Oikawa S. Yamashita S, et al. Among authors: oikawa s. J Atheroscler Thromb. 2022 May 1;29(5):608-638. doi: 10.5551/jat.62764. Epub 2021 May 13. J Atheroscler Thromb. 2022. PMID: 33980760 Free PMC article.
Large-scale cohort study on the relationship between serum lipid concentrations and risk of cerebrovascular disease under low-dose simvastatin in Japanese patients with hypercholesterolemia: sub-analysis of the Japan Lipid Intervention Trial (J-LIT).
Nakaya N, Kita T, Mabuchi H, Matsuzaki M, Matsuzawa Y, Oikawa S, Saito Y, Sasaki J, Shimamoto K, Itakura H; J-LIT Study Group. Nakaya N, et al. Among authors: oikawa s. Circ J. 2005 Sep;69(9):1016-21. doi: 10.1253/circj.69.1016. Circ J. 2005. PMID: 16127179 Free article. Clinical Trial.
Efficacy and Safety of Long-term Coadministration of Fenofibrate and Ezetimibe in Patients with Combined Hyperlipidemia: Results of the EFECTL Study.
Oikawa S, Yamashita S, Nakaya N, Sasaki J, Kono S; Effect of Fenofibrate and Ezetimibe Combination Treatment on Lipid (EFECTL) Study Investigators. Oikawa S, et al. J Atheroscler Thromb. 2017 Jan 1;24(1):77-94. doi: 10.5551/jat.35626. Epub 2016 Jul 8. J Atheroscler Thromb. 2017. PMID: 27397061 Free PMC article. Clinical Trial.
Primary cardiovascular events and serum lipid levels in elderly Japanese with hypercholesterolemia undergoing 6-year simvastatin treatment: a subanalysis of the Japan lipid intervention trial.
Horiuchi H, Kita T, Mabuchi H, Matsuzaki M, Matsuzawa Y, Nakaya N, Oikawa S, Saito Y, Sasaki J, Shimamoto K, Itakura H; J-LIT Study Group. Horiuchi H, et al. Among authors: oikawa s. J Am Geriatr Soc. 2004 Dec;52(12):1981-7. doi: 10.1111/j.1532-5415.2004.52552.x. J Am Geriatr Soc. 2004. PMID: 15571531
Relationship between coronary events and serum cholesterol during 10 years of low-dose simvastatin therapy: long-term efficacy and safety in Japanese patients with hypercholesterolemia in the Japan Lipid Intervention Trial (J-LIT) Extension 10 Study, a prospective large-scale observational cohort study.
Itakura H, Kita T, Mabuchi H, Matsuzaki M, Matsuzawa Y, Nakaya N, Oikawa S, Saito Y, Sasaki J, Shimamoto K; J-LIT Study Group. Itakura H, et al. Among authors: oikawa s. Circ J. 2008 Aug;72(8):1218-24. doi: 10.1253/circj.72.1218. Circ J. 2008. PMID: 18654003 Free article. Clinical Trial.
Relation of Serum Lipoprotein(a) Levels to Lipoprotein and Apolipoprotein Profiles and Atherosclerotic Diseases in Japanese Patients with Heterozygous Familial Hypercholesterolemia: Familial Hypercholesterolemia Expert Forum (FAME) Study.
Naito R, Daida H, Masuda D, Harada-Shiba M, Arai H, Bujo H, Ishibashi S, Koga N, Oikawa S, Yamashita S. Naito R, et al. Among authors: oikawa s. J Atheroscler Thromb. 2022 Aug 1;29(8):1188-1200. doi: 10.5551/jat.63019. Epub 2021 Aug 30. J Atheroscler Thromb. 2022. PMID: 34456199 Free PMC article.
Guidelines for the management of familial hypercholesterolemia.
Harada-Shiba M, Arai H, Oikawa S, Ohta T, Okada T, Okamura T, Nohara A, Bujo H, Yokote K, Wakatsuki A, Ishibashi S, Yamashita S. Harada-Shiba M, et al. Among authors: oikawa s. J Atheroscler Thromb. 2012;19(12):1043-60. doi: 10.5551/jat.14621. Epub 2012 Oct 25. J Atheroscler Thromb. 2012. PMID: 23095242 Free article.
856 results